Zevra Therapeutics, Inc. Convertible Notes Payable, Current
Zevra Therapeutics, Inc. (ZVRA) had Convertible Notes Payable, Current of $65.92 million as of 2020-09-30, per its 10-Q filed 2020-10-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2020-10-30
- 2020-09-30: Convertible Notes Payable, Current $65.92M.
- 2020-06-30: Convertible Notes Payable, Current $67.27M.
- 2020-03-31: Convertible Notes Payable, Current $68.61M.
- 2019-09-30: Convertible Notes Payable, Current $6.72M.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2020-09-30 | $65.92M 10-Q · filed 2020-10-30 | |
| 2020-06-30 | $67.27M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $68.61M 10-Q · filed 2020-05-13 | |
| 2019-09-30 | $6.72M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $6.50M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $6.37M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $3.33M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $3.33M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.33M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $3.33M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $3.33M 10-K · filed 2019-03-01 | |
| 2016-06-30 | $1.93M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.65M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.37M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $1.10M 10-Q · filed 2015-11-13 | |
| 2014-12-31 | $325.00K 10-K · filed 2016-03-16 | $77.00K 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |